検索結果

FDA alerts health care professionals, compounders and patients of potential safety risks associated with sulfite- containing compounded drugs （https://www.fda.gov/drugs/human-drug-compounding/fda-aler...

Production | About Senju | SENJU Pharmaceutical

Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject...

Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical

he world. Senju Pharmaceutical has taken on the challenge of forming the Vision Care Platform along with the pharmaceutical business to support total care in the ophthalmic area (care for presymptomat...

Milestones in Our History | About Senju | SENJU Pharmaceutical

1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb...

Overseas Activities | SENJU Pharmaceutical

Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent...